Application of human serum albumin in the management of end-stage liver disease / 临床肝胆病杂志
Journal of Clinical Hepatology
;
(12): 936-941, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-923313
ABSTRACT
Albumin is the most abundant protein in human plasma, and its oncotic and non-oncotic functions can regulate various functions in human body. In patients with end-stage liver disease, the deterioration of disease conditions and related complications caused by the reduction, loss, and abnormal function of albumin can be alleviated or even improved to some extent after the treatment with human serum albumin. This article reviews recent clinical studies in China and foreign countries, discusses the application and clinical effect of human serum albumin in end-stage liver disease, and points out that effective monitoring of albumin content may become a new indicator for the prognosis and treatment of end-stage liver disease.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of Clinical Hepatology
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS